The World Health Summit brings together leading researchers, physicians, government officials and representatives from industry, non-governmental organizations (NGOs) and health care systems worldwide.
Among the confirmed speakers are:
(in alphabetical order)
Before starting her career at Novartis Pharma, Ann Aerts served as Director of the Lung and Tuberculosis Association in Belgium, as Head of the Health Services Department of the International Committee of the Red Cross (ICRC) in Geneva, and as Health Coordinator for the ICRC in several countries. She holds degrees in Medicine, Public Health and Tropical Medicine.
He is a veteran of the company, having joined in 1996 as a pharmaceutical consultant immediately after graduating from university with a biology degree. He then worked his way up the ranks in Germany including Head of Primary Care and Head of the company's Sales organization.
After graduating from Medicine in Alexandria, he practiced medicine in Scotland and obtained his postgraduate training and qualifications in the UK. Following his return to Iraq he held several positions in clinical and academic medicine and public health. He was Professor and Dean of the Faculty of Medicine, Mustansiriya University, Baghdad, and used to serve as WHO Assistant Director-General for Noncommunicable Diseases and Mental Health.
After studying economics he joined Bayer in the Corporate Finance Department. He held several international positions in the company, including member of the Executive Committee and Head of Central Administration & Organization at Bayer HealthCare and Chief Financial Officer of Bayer AG.
A physician specialized in tropical medicine and public health, he was one of the founding board members of the Global Fund in 2002 and has served in his current position since 2003. Prior to joining the Global Fund, he worked as a clinician and public health official in the UK, Germany and as Doctor-in-Charge of a rural hospital in Tanzania. He has more than 25 years of experience in global health and health advocacy with a special focus on AIDS and infectious diseases.
Formally the Senior Vice President and CFO for Philips Home Healthcare Solutions, he joined Philips from Baxter Healthcare, where he acted as the European Regional Controller. He accumulated more than 20 years of experience in the healthcare industry, recently completing about 25 M&A transactions with a particular focus on targets in the areas of Home Healthcare, Clinical Decision Support, Imaging and Image Guided Intervention and Treatment.
Elizabeth Blackburn won the 2009 Nobel Prize in Physiology or Medicine for discovering the molecular nature of telomeres and the co-discovery of telomerase. Both telomeres and telomerase are thought to play central roles in aging and diseases such as cancer. She has shown an abiding commitment to public service in the scientific, academic and public policy arenas, and helped to guide public science policy.
He was previously the Parliamentary Under Secretary of State at the Department of Health, where he was responsible for social services and mental health. Within this role he published guidelines to end the denial of adoptions purely on the basis of race.
Her previous roles at FIND included Chief Medical Officer (CMO) and Head of the TB program, where she was responsible for clinical evaluation of new tools for diagnosis of TB, malaria and neglected diseases. She has an extensive background in clinical evaluation and played a key role in FIND’s Xpert MTB/RIF feasibility. Prior to joining FIND in 2005, she worked as program coordinator for the Department of Infectious and Tropical Diseases in Munich, Germany, and established a TB research unit at Mbeya Medical Research Program in Tanzania.
An accomplished Corneal Surgeon and Ophthalmologist, Hélène Boisjoly is the first woman to hold the position of Dean of Faculty of Medicine at the University of Montreal and within the greater province of Quebec. She is the International President of the World Health Summit 2017.
He has a PhD in Health Administration, a Master in Public Health and Health Service Administration and graduated in Medicine. A specialist for Public Health, he is Professor at the National School of Public Health, at Universidade Nova de Lisboa, and taught and coordinated several university institutions in management and health administration. He was Senior Manager in health institutions such as Hospital de Santa Maria, Hospital Pulido Valente, Centro Hospitalar Lisboa Norte, Hospital de Cascais, SAMS Prestação Integrada de Cuidados de Saúde.
Prior to his current position, he was the Deputy-Director for International Relations at the Ministry of Health and Social Development of the Russian Federation, a post he occupied from 2005. He joined the Red Cross and Red Crescent Movement in 1987 and worked in several countries affected by conflict as well as natural and technical disasters. He earned a degree in Medicine in 1979, a doctorate of Philosophy in Medical Sciences and worked for 10 years at the primary care level in various states within the former Soviet Union.
The Professor of infectious diseases and bacteriology used to be Executive Director of the Roll Back Malaria Partnership, served as Director of the UNAIDS Department of Country and Regional Support and was Minister of Health and Prevention of Senegal. She has been awarded numerous professional and academic honours.
Previously a Senior Health Policy Analyst in the Health Division, she is now responsible for OECD work on health which aims at providing internationally comparable data on health systems and applying economic analysis to health policies, in this way advising policy makers, stakeholders and citizens on how to respond to healthcare demands.
Working for the NCD Alliance since its founding in 2009, she holds experience in organizational and strategic development, global advocacy and policy-making, program design as well as capacity-building in low- and middle-income countries. Before joining the NCD Alliance, she worked at the International Diabetes Federation (IDF) in Brussels, leading their global advocacy program and establishing the first Women and Diabetes program.
A biochemist and structural biologist trained in basic sciences, his research activities have focused on different topics such as molecular virology, biochemistry, molecular biology, nuclear magnetic resonance, microbiology, structural biology, and bioinformatics. He has chaired numerous grant committees and has sat at councils including the Fondation pour la Recherche Médicale, European Molecular Biology Laboratory and Ecole Normale Supérieure Biology Dpt.
Manfred Dietel has headed the Institute for Anatomic Pathology at the Christian Albrecht University in Kiel since 1989. In 1993, he became Director of the Institute for Anatomic Pathology at the Charité, Humboldt-University in Berlin, and was Dean of its medical faculty from 1997-1999. From 2001-2004 he spent a stint as the Charité’s Medical Director and Managing Director.
She held the Swiss Federal Department of Home Affairs, was the first woman ever to be elected President of the Confederation and won several referendums, including a revision of the Health Insurance Bill, the 10th revision of the social security system, and a drug policy based on prevention, therapy, help and rehabilitation. She is a member of the Council of Women World Leaders.
Professor Karl Max Einhäupl is a trained Neurologist. In 2004, he was awarded the German Federal Cross of Merit. From 1993-2008 Director of the Clinic for Neurology, Charité - Universitätsmedizin Berlin and from 2007 to 2008 Head of the Centre “CC15: Neurology, Neurosurgery and Psychiatry”. Since 2008, he is Chief Executive Officer of the Charité - Universitätsmedizin Berlin.
She graduated with degrees from the University of the West Indies in Jamaica and the London School of Hygiene & Tropical Medicine, UK, was the Director of Primary Health Care Services, Disaster Coordinator, a National Epidemiologist in the Ministry of Health, Coordinator of the National AIDS Program, Chair of the National AIDS Committee and undertook two separate terms as Chief Medical Officer. She was the Assistant Director of PAHO, served as the Assistant Director-General of Health Systems and Services at the WHO and was elected PAHO director in September 2012.
A professor of Public Health at University Descartes, Sorbonne Paris Cité, he is chair of the Centre Virchow Villermé de Santé Publique Paris-Berlin, co-chairs the European Academic Global Health Alliance, is president of the European Agency for Public Health Education Accreditation and Founding Director of the Institute of Global Health, University of Geneva. In 2016, Antoine Flahault was the International President of the World Health Summit.
With an impressive track record as a business executive - most recently as CEO of Lufthansa - and an exceptional global network, he has been a member of the Roche board since 2011 and was elected as Chair in 2014.
A specialist in pharmacology and molecular medicine, Detlev Ganten is one of the world’s top scientists in the field of hypertension. He is the Founding President of the World Health Summit, a former CEO of the Charité – Universitätsmedizin Berlin and Founding Director and CEO of the Max Delbrück Center for Molecular Medicine.
Since 2004, Laurie Garrett has been a senior fellow for global health at the Council on Foreign Relations in New York. Garrett is the only writer ever to have been awarded all three of the Big "Ps" of journalism: the Peabody, the Polk, and the Pulitzer. Her expertise includes global health systems, chronic and infectious diseases, and bioterrorism.
A pharmacist by profession, she was involved in humanitarian work and has been a member of the Inner Wheel Club of Abidjan. She is strongly committed to the promotion of women in decision-making positions in political, economic and social domains. She specialized in fundraising and has held numerous training courses on leadership and management.